# Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria Saliva and Bioaerosol Contamination Phase 2

> **NCT04717063** · PHASE2 · COMPLETED · sponsor: **Colgate Palmolive** · enrollment: 100 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Peroxyl Oral Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04717063
- **Lead sponsor:** Colgate Palmolive
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-16
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-01-07
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04717063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04717063, "Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria Saliva and Bioaerosol Contamination Phase 2". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04717063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*